Fatal pulmonary microthrombi during surgical therapy for end-stage heart failure: possible association with antifibrinolytic therapy.

[1]  R. Hetzer,et al.  Hemostatic Activation and Inflammatory Response during Cardiopulmonary Bypass: Impact of Heparin Management , 2002, Anesthesiology.

[2]  D. Haskard,et al.  The antithrombotic and antiinflammatory mechanisms of action of aprotinin. , 2001, The Annals of thoracic surgery.

[3]  J. Levy.  Pharmacologic preservation of the hemostatic system during cardiac surgery. , 2001, The Annals of thoracic surgery.

[4]  C. Hogue,et al.  Mechanisms and attenuation of hemostatic activation during extracorporeal circulation. , 2001, The Annals of thoracic surgery.

[5]  D. Raines,et al.  Aprotinin administration and pulmonary thromboembolism during orthotopic liver transplantation: report of two cases. , 2001, Anesthesia and analgesia.

[6]  E. Norfleet,et al.  Fatal thrombosis associated with a hemi-fontan procedure, heparin-protamine reversal, and aprotinin. , 2001, Anesthesiology.

[7]  M. Prins,et al.  Pharmacological strategies to decrease excessive blood loss in cardiac surgery: a meta-analysis of clinically relevant endpoints , 1999, The Lancet.

[8]  G. Gravlee,et al.  Anticoagulation Monitoring during Cardiac Surgery , 1999 .

[9]  G. Gravlee,et al.  Anticoagulation monitoring during cardiac surgery: a review of current and emerging techniques. , 1999, Anesthesiology.

[10]  John D. Birkmeyer,et al.  Is ε-Aminocaproic Acid as Effective as Aprotinin in Reducing Bleeding With Cardiac Surgery? A Meta-Analysis , 1999 .

[11]  S. Noble,et al.  Aprotinin , 2012, Drugs.

[12]  B. Chaitman,et al.  Analyses of coronary graft patency after aprotinin use: results from the International Multicenter Aprotinin Graft Patency Experience (IMAGE) trial. , 1998, The Journal of thoracic and cardiovascular surgery.

[13]  C. R. Smith,et al.  Management of bleeding complications in redo cardiac operations. , 1998, The Annals of thoracic surgery.

[14]  M. Csete,et al.  Fatal pulmonary embolism during liver transplantation. , 1997, Anesthesiology.

[15]  J. Copeland,et al.  Aprotinin for primary coronary artery bypass grafting: a multicenter trial of three dose regimens. , 1996, The Annals of thoracic surgery.

[16]  S. Haddy,et al.  Intravascular thrombosis after exsanguination in a patient treated with epsilon-aminocaproic acid. , 1996, Journal of cardiothoracic and vascular anesthesia.

[17]  M. Oz,et al.  Safety of repeat aprotinin administration for LVAD recipients undergoing cardiac transplantation. , 1996, The Annals of thoracic surgery.

[18]  M. Pfisterer,et al.  Aprotinin in Aortocoronary Bypass Surgery: Increased Risk of Vein-Graft Occlusion and Myocardial Infarction? Supportive Evidence from a Retrospective Study , 1996, Thrombosis and Haemostasis.

[19]  M. Oz,et al.  Use of aprotinin in LVAD recipients reduces blood loss, blood use, and perioperative mortality. , 1995, The Annals of thoracic surgery.

[20]  P. Feindt,et al.  Celite and Kaolin Produce Differing Activated Clotting Times during Cardiopulmonary Bypass under Aprotinin Therapy , 1994, The Thoracic and cardiovascular surgeon.

[21]  R. Berger,et al.  Heparin resistance after preoperative heparin therapy or intraaortic balloon pumping. , 1994, The Annals of thoracic surgery.

[22]  C. Tatooles,et al.  Aprotinin for coronary bypass operations: efficacy, safety, and influence on early saphenous vein graft patency. A multicenter, randomized, double-blind, placebo-controlled study. , 1994, The Journal of thoracic and cardiovascular surgery.

[23]  H. Huwer,et al.  Is there a phase of hypercoagulability when aprotinin is used in cardiac surgery? , 1994, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[24]  T. Sundt,et al.  Renal dysfunction and intravascular coagulation with aprotinin and hypothermic circulatory arrest. , 1993, The Annals of thoracic surgery.

[25]  B. Hunt,et al.  Aprotinin and Heparin Monitoring During Cardiopulmonary Bypass , 1992, Circulation.

[26]  M. Spannagl,et al.  The influence of preoperative anticoagulation on heparin response during cardiopulmonary bypass. , 1991, The Journal of thoracic and cardiovascular surgery.

[27]  C. Vahl,et al.  Early formation of thrombi on pulmonary artery catheters in cardiac surgical patients receiving high-dose aprotinin. , 1990, Journal of cardiothoracic anesthesia.